Luke Steventon is a Volunteer Writer at BioNews, having originally joined under the auspices of its writing scheme. He is an early career researcher with a background in cancer clinical trials and observational studies. Luke is currently completing a PhD at University College London, carrying out research into disparities in cancer treatment outcomes between patients from different ethnic, socioeconomic and regional backgrounds. He is also involved in the development of a prognostic machine learning model to predict organ dysfunction in patients on chemotherapy and work on other NIHR funded research.
The first patient in England to receive a personalised bowel cancer vaccine has been treated in a Birmingham hospital...
Early safety data of a potential CRISPR-based genome editing therapy for HIV have been reported...
Just three out of 42 Integrated Care Boards are offering the recommended three full NHS-funded IVF cycles across their entire area, analysis by the Progress Educational Trust has shown...
A new machine learning tool can profile the genetics of brain tumour cells in real-time, informing rapid treatment decisions during surgery...
Luke Steventon reviews a radio programme about mitochondria, which are described as producing energy production levels of '30 million volts per metre – like a bolt of lightning'...
A compound found in a common artificial sweetener can cause damage to DNA in human cells...
Polygenic scores can enhance the accuracy of prostate cancer screening tests to detect aggressive cancers and help avoid some unnecessary biopsies...
A biobank scheme will be piloted in England to study links between patients' genomes and their risk of adverse drug reactions...
An embryologist has won claims of whistleblowing detriment and unfair dismissal against a Scottish private fertility clinic...
Model livers, which contain cells that are genetically identical to tumour cells, have been developed to study a rare paediatric liver cancer...
Stay up-to-date on all the latest developments in the fields of human fertility and genomics. And be the first to hear about upcoming events and other announcements.
